AstraZeneca sees share price surge after FDA backs Crestor drug

LONDON : AstraZeneca led London's FTSE 100 index of blue-chip shares after the US Food and Drug Administration (FDA) backed the Anglo-Swedish pharmaceuticals giant's anti-cholesterol drug Crestor.

Continue to AstraZeneca sees share price surge after FDA backs Crestor drug on Misc sources.

Guarantee finance is a leading newssite providing news about stocks, markets, finance, mortgage rates, refinancing, home loans, equity, consolidation and currencies. Click below for more finance news.
Guarantee finance